Literature DB >> 23113765

Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.

Randall Reif1, Farzin Haque, Peixuan Guo.   

Abstract

Due to the discovery of more and more roles of cellular noncoding RNAs, the approaches for introducing RNAs including small interfering RNA (siRNA), micro RNA (miRNA), ribozyme, and riboswitch into cells for regulating cell life cycle and for the treatment of diseases have become routine practice. The understanding of RNA folding, degradation, and intracellular half-life after entering the cell is an intriguing question in biology and pharmacology. Currently, methods to detect RNA folding, degradation, and half-life in real time within the cell is extremely challenging. The common assay method to measure RNA half-life and degradation in vivo is the use of radioactive markers or fluorescence RNA labeling. The challenge is, after RNA becomes degraded or misfolded, the isotope or the fluorescence is still present in the cell, thus the signals are not a true indication of the presence of the RNA in the cell. The alternate method commonly used to measure RNA life is to isolate RNA from cells and distinguish between intact and degraded RNA by gel, chromatography, or capillary electrophoresis. However, when a cell is breaking down, ribonucleases (RNases) will be released from cell compartments, and degradation of small RNA in cell lysates occurs immediately after cell lysis. Here we report a method to monitor RNA degradation in real time in living cells using fluorogenic RNA in combination with RNA nanotechnology (Guo, 2010; Guo et al., 2012). The RNA aptamer that binds malachite green (MG), the ribozyme that cleaves the hepatitis virus genome, and a siRNA for firefly luciferase were all fused to the bacteriophage phi29 packaging RNA (pRNA) 3-way junction (3WJ) motif to generate RNA nanoparticles. The MG aptamer, the hepatitis B virus ribozyme, and the luciferase siRNA all retained their function independently after fusion into the nanoparticles. When the RNA nanoparticle is degraded, denatured, or misfolded, the fluorescence disappears. MG, which is not fluorescent by itself, is capable of binding to its aptamer and emitting fluorescent light only if the RNA remains folded in the correct conformation. Therefore, the MG aptamer fluorescence (in the presence of MG dye) can be used as a measure of the degradation and folding of RNA nanoparticles, the siRNA, the aptamer, and the ribozyme in the cell in real time using epifluorescence microscopy and fluorescence spectroscopy without lysing the cells. We show that the half-life (t½) of the electroporated MG aptamer containing RNA nanoparticle was 4.3 hours after electroporation into cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23113765      PMCID: PMC3507523          DOI: 10.1089/nat.2012.0380

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  40 in total

1.  Sequence requirement for hand-in-hand interaction in formation of RNA dimers and hexamers to gear phi29 DNA translocation motor.

Authors:  C Chen; C Zhang; P Guo
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

2.  Medicine: silencing viruses with RNA.

Authors:  Gordon G Carmichael
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

3.  Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology.

Authors:  Dan Shu; Wulf-Dieter Moll; Zhaoxiang Deng; Chengde Mao; Peixuan Guo
Journal:  Nano Lett       Date:  2004-09       Impact factor: 11.189

Review 4.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

Review 5.  RNA folding: conformational statistics, folding kinetics, and ion electrostatics.

Authors:  Shi-Jie Chen
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

6.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

7.  A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNA.

Authors:  P X Guo; S Erickson; D Anderson
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

Review 8.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

9.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.

Authors:  C Guerrier-Takada; K Gardiner; T Marsh; N Pace; S Altman
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.

Authors:  S Guo; F Huang; P Guo
Journal:  Gene Ther       Date:  2006-05       Impact factor: 5.250

View more
  21 in total

1.  RNA nanotechnology for computer design and in vivo computation.

Authors:  Meikang Qiu; Emil Khisamutdinov; Zhengyi Zhao; Cheryl Pan; Jeong-Woo Choi; Neocles B Leontis; Peixuan Guo
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2013-09-02       Impact factor: 4.226

2.  One-Pot Production of RNA Nanoparticles via Automated Processing and Self-Assembly.

Authors:  Daniel L Jasinski; Daniel W Binzel; Peixuan Guo
Journal:  ACS Nano       Date:  2019-03-22       Impact factor: 15.881

Review 3.  Single molecule photobleaching (SMPB) technology for counting of RNA, DNA, protein and other molecules in nanoparticles and biological complexes by TIRF instrumentation.

Authors:  Hui Zhang; Peixuan Guo
Journal:  Methods       Date:  2014-01-15       Impact factor: 3.608

4.  Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs.

Authors:  Emil F Khisamutdinov; Daniel L Jasinski; Hui Li; Kaiming Zhang; Wah Chiu; Peixuan Guo
Journal:  Adv Mater       Date:  2016-10-19       Impact factor: 30.849

5.  Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

Authors:  Yi Shu; Farzin Haque; Dan Shu; Wei Li; Zhenqi Zhu; Malak Kotb; Yuri Lyubchenko; Peixuan Guo
Journal:  RNA       Date:  2013-04-19       Impact factor: 4.942

Review 6.  Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.

Authors:  Congcong Xu; Farzin Haque; Daniel L Jasinski; Daniel W Binzel; Dan Shu; Peixuan Guo
Journal:  Cancer Lett       Date:  2017-10-05       Impact factor: 8.679

Review 7.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Authors:  Yi Shu; Fengmei Pi; Ashwani Sharma; Mehdi Rajabi; Farzin Haque; Dan Shu; Markos Leggas; B Mark Evers; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

Review 8.  Discovery of a new motion mechanism of biomotors similar to the earth revolving around the sun without rotation.

Authors:  Peixuan Guo; Chad Schwartz; Jeannie Haak; Zhengyi Zhao
Journal:  Virology       Date:  2013-08-27       Impact factor: 3.616

Review 9.  RNA modularity for synthetic biology.

Authors:  Wade Grabow; Luc Jaeger
Journal:  F1000Prime Rep       Date:  2013-11-01

10.  Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.

Authors:  Dan Shu; Emil F Khisamutdinov; Le Zhang; Peixuan Guo
Journal:  Nucleic Acids Res       Date:  2013-09-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.